Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Shinobi Therapeutics logo — company profile

Shinobi Therapeutics

Founded 2023 United States South San Francisco, United States 40 employees Series A Total: $51.00M Biotechnology, Health and Wellness

General Information

Company Name Shinobi Therapeutics
Founded Year 2023
Location United States South San Francisco, United States +2
Employees 40
Industries Biotechnology, Health and Wellness
Funding Stage Series A
Social

Get notified when Shinobi Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Shinobi Therapeutics

Shinobi Therapeutics is a biotechnology startup founded in 2023 and headquartered in the United States. The company is focused on developing a new class of hypoimmune CD8ab iPS-T cells for cancer and beyond, leveraging immune evasion to unlock the full potential of iPSCs.

The startup recently secured a significant $51.00M Series A investment on 12 December 2023. This round of funding involved a consortium of notable investors including F-Prime Capital, Life Science Partners, Astellas Venture Management, JIC Venture Growth Investments, D3, Fast Track Initiative, Inc., and Eight Roads Ventures Japan.

Overall, Shinobi Therapeutics' innovative approach and substantial Series A investment showcase its potential for advancing cutting-edge biotechnological solutions in the fight against cancer and potentially other diseases.

Taxonomy: Immunotherapy, Cancer treatment, Cell Therapy, Stem Cells, Immune system, iPSCs, Therapeutics, Immune evasion, Innovation, Medical Research

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 7
Investor Investor Investor Investor Investor
•••• •••• 		12 Dec 2023

Shinobi Therapeutics Alternatives & Competitors

Shinobi Therapeutics vs
Nuvig Therapeutics Inc.
Nuvig Therapeutics Inc. United States

Rebalancing Immune Function for Chronic Inflammatory and Autoimmune Diseases

Series A
24 employees
Biotechnology, Health Care
Compare Shinobi Therapeutics vs Nuvig Therapeutics Inc.
Shinobi Therapeutics vs
Georgiamune Inc.
Georgiamune Inc. United States

Georgiamune is reprogramming immune signaling pathways to redirect the immune system to fight diseas...

Series A
30 employees
Biotechnology, Health Care
Compare Shinobi Therapeutics vs Georgiamune Inc.
Shinobi Therapeutics vs
ImmunoGenesis, Inc.
ImmunoGenesis, Inc. United States

Re-envisioning cold tumor treatment. Our deliberate drug development strategy targets mechanisms of...

Series Unknown
14 employees
Biotechnology, Health Care
Compare Shinobi Therapeutics vs ImmunoGenesis, Inc.

FAQ About Shinobi Therapeutics

Shinobi Therapeutics is developing a new class of hypoimmune CD8ab iPS-T cells for cancer and beyond by using immune evasion to unlock the full potential of iPSCs.
Shinobi Therapeutics was founded in 2023.
Shinobi Therapeutics is headquartered in South San Francisco, United States.
Shinobi Therapeutics operates in the following industries: Biotechnology, Health and Wellness.
Shinobi Therapeutics has approximately 40 employees.
Shinobi Therapeutics has completed 1 funding round, raising a total of $51.00M. The latest funding stage is Series A.
Top alternatives and competitors to Shinobi Therapeutics include Nuvig Therapeutics Inc., Georgiamune Inc., ImmunoGenesis, Inc., Hanimune Therapeutics, Inflazome. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Shinobi Therapeutics and Nuvig Therapeutics Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Shinobi Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes